Statsrådets förordning om undantag vid uttagande av självriskandelen som avses i 5 kapitlet 9 § 5 mom. i sjukförsäkringslagen | 199 — Finland law | Esheria

Statsrådets förordning om undantag vid uttagande av självriskandelen som avses i 5 kapitlet 9 § 5 mom. i sjukförsäkringslagen

For reimbursement calculations under the cited health insurance rules, the drug-specific self-risk share is charged exceptionally for listed medicines used for long-term treatment, for an amount equal to three months of treatment even if bought in several partial purchases.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
Finland
Instrument
Regulation
Citation
199
Version
Undated source snapshot
Language
sv
Official source
View official record ↗
dose dispensing drug reimbursement patient cost-sharing pharmaceutical reimbursement

Publicly available, excluded from search-engine indexing

This page remains available for direct access and API use, but this release emits noindex,follow for the following reason:

  • The record does not meet this release's canonical indexing criteria. (market-indexing-disabled)

Statute overview

About this statute

For reimbursement calculations under the cited health insurance rules, the drug-specific self-risk share is charged exceptionally for listed medicines used for long-term treatment, for an amount equal to three months of treatment even if bought in several partial purchases. The drug-specific deductible may exceptionally be charged when reimbursement is calculated for certain medicines, if the medicines were obtained through several partial purchases during a three-month treatment period and dose dispensing was carried out under the cited health insurance rules. Förordningen träder i kraft den 1 april 2009. Åtgärder som behövs för verkställigheten får vidtas innan dess. En tidigare statsrådsförordning upphävs genom denna förordning.

Available versions

  • Undated version · current

    fi

  • Undated version · current

    sv